SMFG
GILD icon

Sumitomo Mitsui Financial Group’s Gilead Sciences GILD Stock Holding History

Sumitomo Mitsui Financial Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,000
Closed -$10K – 201
2021
Q4 		$10K Hold
5,000
– – ﹤0.01% 185
2021
Q3 		$13K Hold
5,000
– – ﹤0.01% 178
2021
Q2 		$10K Buy
+5,000
New +$334K ﹤0.01% 158

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sumitomo Mitsui Financial Group's GILD Position: Q1 2022 in Review

Sumitomo Mitsui Financial Group sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 280 shares — an estimated $21K sold.

Sumitomo Mitsui Financial Group first reported a position in GILD in Q2 2017 and held it in 8 quarters. The position peaked at $168K in Q3 2019. 1,600 funds tracked by Wall St. Rank hold GILD as of Q1 2022.

  • Sumitomo Mitsui Financial Group reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
  • Sumitomo Mitsui Financial Group sold 280 Gilead Sciences shares in Q1 2022, an estimated $21K.
  • Sumitomo Mitsui Financial Group first reported a position in Gilead Sciences in Q2 2017 and held it in 8 quarters.
  • Sumitomo Mitsui Financial Group's Gilead Sciences position peaked at $168K in Q3 2019.
  • 1,600 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.

Based on Sumitomo Mitsui Financial Group's 13F filing for Q1 2022, filed 12 May 2022.